Healthcare Private Placement and M&A Transactions Review Week Ending January 29 2023

Alleviant Medical: The company raised $75 million of venture funding in a deal led by S3 Ventures and RiverVest Venture Partners on January 26, 2023. Vensana Capital, Gilmartin Capital, ShangBay Capital, Texas Medical Center, Long View Equity Partners, and other undisclosed investors also participated in the round. The company’s device relieves pressure buildup in the left atrium of the heart that can possibly lead to organ failures.

Grey Wolf Therapeutics: The company raised $49 million of Series B venture funding in a deal led by Pfizer Ventures and Earlybird Venture Capital on January 26, 2023. Andera Partners, British Patient Capital, Canaan Partners, and Oxford Science Enterprises also participated in the round. The company’s therapies drive modulation of the neo-antigen repertoire on tumor cells to increase tumor visibility and extend the reach of immunotherapy in oncology.

Precision Neuroscience: The company raised $41 million of Series B venture funding in a deal led by Forepont Capital Partners on January 25, 2023. Steadview Capital Management, B Capital Group, Mubadala Capital-Ventures, Draper Associates, Alumni Ventures and re.Mind Capital also participated in the round. The company uses neural technology to develop a minimally invasive delivery of brain-computer implants.

Atomic AI: The company raised $35 million of Series A venture funding in a deal led by Playground Global on January 25, 2023. 8VC, FactoryHQ, Greylock Partners, Not Boring, AME Cloud Ventures, Nat Friedman, Doug Mohr, Neal Khosla and Patrick David Hsu also participated in the round. The company is an operator of a content intelligence platform designed to enable the design of new molecules and medicine using AI.

Miach Orthopaedics: The company raised $30 million through the combination of debt and Series B venture funding in a deal led by Endeavour Vision and Sectoral Asset Management on January 25, 2023. DSM Venturing, NFL Players Association, Smith & Nephew, and Amzak Health also participated in the round. The company is a developer of bio-engineered surgical implants designed to facilitate new tissue growth and aid in connective tissue repair for ACL injuries.

iVexSol: The company raised $23.8 million of Series A3 venture funding from Biolife Solutions, Bristol-Myers Squibb and Charles River Laboratories International on January 26, 2023. Asahi Kasei Medical and Casdin Capital also participated in the round. The company is a developer of lentiviral vector technology designed to supply a consistent source of vectors for successful gene therapy programs.

UptimeHealth: The company raised $4.5 million of venture funding in a deal led by Wavemaker Three-Sixty Health and Caduceus Capital Partners on January 26, 2023. The company is a developer of equipment management software designed to reduce costs and improve the quality of medical services.

Longevity Biomedical / Denali Capital Acquisition: The company reached a definitive agreement to acquire Denali Capital Acquisition through a reverse merger, resulting in the combined entity trading on the NASDAQ Stock Exchange under the ticker symbol LBIO on January 25, 2023. The company provides a range of biopharmaceutical products focused on diseases of aging.

NVOLVE / CoachCare: The company was acquired by CoachCare for an undisclosed amount on January 26, 2023.The company is a developer of medication adherence, monitoring, and intervention system designed to track the consumption of pills and send alerts when a medication is not taken or is taken improperly.

Siva Therapeutics / Sona Nanotech: The company was acquired by Sona Nanotech for an undisclosed amount on January 26, 2023. The company is a biotechnology business intended to develop practical, safe, and cost-effective device therapy for cancer.

SolveBio / QuartzBio: The company was acquired by QuartzBio, a subsidiary of Precision Medicine Group, for an undisclosed amount on January 24, 2023. The company is a developer of a genomic intelligence platform for precision medicine.

SwiftMD / Eir Partners: The company was acquired by ReviveHealth, via its financial sponsor Eir Partners, through an LBO on January 24, 2023 for an undisclosed amount. The company is a provider of telemedicine services intended to offer an easy way for patients and caregivers to connect with physicians for non-emergency medical care.